Cathie Wood's Ark Sells $22M Worth Of Tesla Shares Following Blockbuster Q3 Rally
On Thursday Oct. 24, 2024, Ark Invest, led by Cathie Wood, sold 85,456 Tesla shares valued at $22.22 million amid the stock's ...
Vertex Pharmaceuticals (VRTX) Gets a Buy from Evercore ISI
Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...
Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Opinion
Zacks.com on MSN17hOpinion
5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright
It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major ...
bovnews17h
Vertex Pharmaceuticals Incorporated (VRTX) Stock Dilemma: A Drop That Has Everyone Talking—What’s the Real Story?
On Wednesday, Vertex Pharmaceuticals Incorporated (VRTX) stock saw a decline, ending the day at $470.05 which represents a decrease of $-4.86 or -1.02% from the prior close of $474.91. The stock ...
ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their ...